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REVIEW ARTICLE OPEN
Patient-reported outcome measures for asthma:
a systematic review
Allison Worth1, Victoria Hammersley1, Rebecca Knibb2, Bertine Flokstra-de-Blok3,4, Audrey DunnGalvin5, Samantha Walker1,6,
Anthony EJ Dubois3,7 and Aziz Sheikh1,8
BACKGROUND: Patient-reported outcome measures (PROMs) are measures of the outcome of treatment(s) reported directly by the
patient or carer. There is increasing international policy interest in using these to assess the impact of clinical care.
AIMS: To identify suitably validated PROMs for asthma and examine their potential for use in clinical settings.
METHODS:We systematically searched MEDLINE, EMBASE and Web of Science databases from 1990 onwards to identify PROMs for
asthma. These were critically appraised, then narratively synthesised. We also identified the generic PROMs commonly used
alongside asthma-specific PROMs.
RESULTS: We identified 68 PROMs for asthma, 13 of which were selected through screening as being adequately developed to
warrant full-quality appraisal: 8 for adults, 4 for children and 1 for a child’s caregiver. The PROMs found to be sufficiently well
validated to offer promise for use in clinical settings were the Asthma Quality of Life Questionnaire (AQLQ) and mini-AQLQ for
adults, and Pediatric Asthma Quality of Life Questionnaire for children. Rhinasthma was considered promising in simultaneously
assessing the impact of asthma and rhinitis in those with coexistent disease. We identified 28 generic PROMs commonly used in
conjunction with asthma-specific instruments.
CONCLUSIONS: We identified asthma PROMs that offer the greatest potential for use in clinical settings. Further work is needed to
assess whether these are fit-for-purpose for use in clinical practice with individual patients. In particular, there is a need to ensure
these are validated for use in clinical settings, acceptable to patients, caregivers and clinicians, and yield meaningful outcomes.
npj Primary Care Respiratory Medicine (2014) 24, 14020; doi:10.1038/npjpcrm.2014.20; published online 26 June 2014
INTRODUCTION
In recent decades, our understanding of how health and disease
are best measured has changed very considerably. For example,
we now know that physiological measures often correlate poorly
with functional capacity and well-being1 and patients with the
same clinical criteria often have dramatically different responses
to the impact of symptoms on their lives, this highlighting the
subjective perception of disease impact. Outcome measures have
been developed that reflect the patient perspective, aiming to
understand symptom experiences and the impact of illness.
Disease-specific, rather than generic, outcome measures aim to
provide a focused picture of the day-to-day concerns of patients,
and capture changes in health-related quality of life (HRQL) that
may occur as a result of clinical treatment and care. These
developments in outcome measurement have influenced the
health policy agenda worldwide. In the United Kingdom (UK), they
underpin the move towards routine use of patient-reported
outcome measures (PROMs) in clinical practice.
PROMs are measures of the outcome of treatment that are
reported directly by the patient or carer.2 They are typically
short, self-completed questionnaires, most commonly used to
measure patients’ health status or HRQL before and after an
intervention.3 Over 3,000 generic and disease-specific PROMs
exist4 and these are now commonly used in research contexts,
particularly in clinical trials. The National Health Service in England
routinely collects PROM data from patients undergoing certain
surgical procedures to assess quality of care from the patient’s
perspective. Pilot work has been completed into their use for long-
term conditions, including asthma and chronic obstructive
pulmonary disease, in primary care.5 PROMs data could potentially
contribute to determinants of service quality, so that patient
assessments of the quality of their experiences could be
compared across services and between providers and have an
impact on The National Health Service funding6 and patient
choice.
The use of PROMs in clinical settings to demonstrate improved
health and support clinical decision-making raises a number of
challenges for clinicians, such as how to identify and choose
clinically relevant, valid instruments and when and how to
administer them. The acceptability of PROMs to patients and
clinicians is not well evaluated. Assessing comorbidities is
problematic, as patients with more than one condition may need
to complete several disease-specific measures and a generic
measure. Clinicians may lack knowledge of how to analyse and
interpret PROM data, and if/how they can be utilised to assess
changes over time in people with long-term conditions.5–13
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It is apparent from the literature that a PROM may include the
patient’s perception of symptoms, well-being, health/functional
status, HRQL, satisfaction with treatment and outcomes, and
perceptions of the humanity of care.2,7 We wished to focus on
PROMs that measure health status rather than satisfaction with
care and treatment; the latter are more accurately termed ‘patient-
reported experience measures’.14 Unable to identify a clear,
comprehensive definition of a PROM from the literature to guide
our selection of PROMs, we proposed the working definition given
in Box 1.
Asthma is one of the most common long-term medical
conditions in the world, with an estimated 300 million people
affected.15 The majority of asthma hospital admissions and deaths
are thought to be preventable.16 Asthma can have considerable
impact on personal health and well-being across the age
spectrum; therefore PROMs have considerable potential in
assessing the impact of asthma on HRQL from the perspective
of patients and their caregivers.
Our study set out to identify all available disease-specific PROMs
for asthma in children and adults (i.e., articles where the PROM
was published first and its development described); identify and
appraise the relevant methodological work reporting on devel-
opment and validation of the PROMs; identify which generic
PROMs are used in conjunction with the asthma-specific PROMs
identified; identify what PROMS might be suitable for clinical use;
and identify gaps in the PROMs available for asthma.
MATERIALS AND METHODS
We conducted a systematic literature review and report here on the
asthma PROMs appraised. As the detailed study protocol has previously
been reported,17 we provide below an overview of the methods employed.
Search strategy
We searched the MEDLINE, EMBASE and Web of Science databases for
relevant studies (see Supplementary Appendix 1 for search strategies). We
also searched the PROQOLID (http://www.proqolid.org), PROMIS (http://
www.nihpromis.org) and American Thoracic Society QOL resource (http://
qol.thoracic.org/) websites for relevant tools that may not have been
published.
Searches were limited to the literature from 1990 to 2012, based on the
date of first publication of key PROMs such as the Asthma Quality of Life
Questionnaire (AQLQ).18 Additional references were sought by searching
the references cited by the identified studies, and unpublished work and
research in progress was sought through discussion with experts in the
field, and by searching the National Institute of Health Research and
Agency for Healthcare Research and Quality databases. We invited experts
who are active in the field from a range of disciplines and geographical
locations to comment on our search strategy and the list of included
studies. There was no language restriction, and where possible all literature
was translated for initial screening. Titles and abstracts were screened by
two reviewers, and the PROMs that had more than one paper reporting
psychometric properties and those validated in the English language were
selected for full appraisal.
Quality appraisal, and data synthesis and interpretation
We appraised the original paper describing the tool development and
validation and subsequent associated papers describing further
developments in validation of the tool, including validation in additional
languages. The psychometric properties of each selected PROM were
assessed in detail by two researchers using a quality appraisal tool
developed by Pesudovs et al.19 They then compared their appraisals and
resolved any discrepancies via discussion. We also had to take into account
that the quality appraisal tool we used reflects contemporary standards of
statistical analysis; we therefore adjusted our expectations from papers
published in earlier years—for example, before Rasch analysis was
established. A narrative synthesis summarising the development and
validation of each PROM was also written by the appraisers. On the basis of
this quality appraisal, we then considered whether tools were ready for
clinical use and which of them needed further developmental work.
RESULTS
Search results
Our searches identified 6,316 papers, from which we identified
593 papers on PROMs’ developmental work. Among these, we
identified 68 PROMs for asthma; 13 were selected through
screening as being sufficiently well developed and validated to
merit full-quality appraisal: 8 for adults, 4 for children and 1 for a
child’s caregiver (see Preferred Reporting Items for Systematic
Reviews and Meta-Analyses flow diagram, Figure 1).
Box 1 Definition of a PROM
‘A PROM for a long-term condition is a measure of the impact
and/or the outcome of treatment for that condition on a
patient’s quality of life, reported directly by the patient or carer.
This may include impact of the condition on health-related
quality of life, perceptions of health/functional status related to
the long-term condition and the impact of treatment/care on the
patient’s quality of life.’
MEDLINE
(n =960)
EMBASE
(n =2,142)
Web of
Science
(n =3,214)
Rejected
(n =4,064)
Titles identified for
review
n =6,316
(asthma and allergy)Titles and
abstracts
reviewed &
removed
duplicates
(n =1,659)
Titles and abstracts
double screened
(n =4,657)
Provisionally selected
for quality appraisal
593 full papers
(asthma and allergy)
Allergy papers
separated for
separate analysis/
publication (n =264)
68 asthma PROMs
identified/screened for
development/ validation
work (329 papers)
Not quality appraised:
insufficient development/
validation work reported
(n =55 PROMs, 244 papers)
Full-quality appraisal:
13 asthma PROMs
(85 papers)
Figure 1. Preferred Reporting Items for Systematic Reviews and
Meta-Analyses flow diagram. PROM, patient-reported outcome
measure.
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Quality appraisal
The characteristics of the selected instruments are detailed in
Table 1, and the quality appraisal in Tables 2 and 3. The narrative
review of the 13 selected instruments is presented in
Supplementary Appendix 2.
Many studies provided inadequate information on the devel-
opment or validation of the PROM. There is understandably less
validation work on the PROMs developed recently, such as
Rhinasthma,20 compared with those published 20 years ago, such
as the AQLQ.18
Instruments for use in adults with asthma
The PROMs for adult asthma that we found to be sufficiently well
validated to offer promise for use in clinical settings were the
AQLQ18 and its derivative, the mini-AQLQ.21 The Living with
Asthma Questionnaire22 and Marks Asthma Quality of Life
Questionnaire23 were both appraised as being adequately
developed, but quality appraisal of their performance was
considered unsatisfactory. We found insufficient published data
to appraise the development of the St George’s Respiratory
Questionnaire,24 although it performed well in appraisal of its
psychometric properties.25 The short forms, the Airways Ques-
tionnaire 20 and 30,26,27 although potentially useful because of
their shortened format, require further validation before they can
be recommended. Rhinasthma is promising as a combined
asthma/rhinitis PROM.20 The Asthma Control Test28 and the
Asthma Control Questionnaire29 for adults are promising
measures of asthma control, but focus mainly on symptoms
and/or functional status rather than how these affect the
Table 1. Characteristics of included instruments
Instrument Aim of the instrument and
target population
No. of
validation
papers
assessed
No. of items/domains Mode of administration Time to
complete
Original
language
Asthma PROMs for adults
Asthma Control
Test (ACT)28
Aim: to identify patients with
poorly controlled asthma
Intended population: 12+
years
9 5 questions Self-complete, paper
or web-based
2min English
Asthma Control
Questionnaire
(ACQ)29
Aim: to measure the
adequacy of clinical asthma
control
Intended population: adults
with asthma
11 7 items
Symptoms (5 items)–ß2-agonist
use (1 item)–FEV1 (completed
by clinic staff, 1 item)
Omitting the last item leaves a
6-question version (ACQ6)
Self-complete,
interactive web,
electronic
3 min English
Asthma Quality of
Life Questionnaire
(AQLQ)18
Aim: to measure the
functional problems
(physical, emotional, social
and occupational) that are
most troublesome to adults
(17–70 years) with asthma.
Intended population: adults
with asthma
17 32 questions in 4 domains:
Symptoms (12 items)
Activity limitation (11 items)
Emotional function (5 items)
Environmental stimuli (4 items)
Self-complete
Electronic version
Interactive voice
response version
Interviewer-
administered
5–10min English
Living With
Asthma
Questionnaire
(LWAQ)22
Aim: to evaluate the
effectiveness of treatment; to
be sensitive to quality of life
changes in clinical trials; to
assess patients’ subjective
experiences of asthma
Intended population: adults
with asthma
8 68 items in 11 domains:
Social/leisure (6 items)
Sport (3 items)
Holidays (3 items)
Sleep (4 items)
Work and other activities
(6 items)
Colds (5 items)
Mobility (6 items)
Effects on others (5 items)
Medication usage (6 items)
Sex (1 item)
Dysphoric states and attitudes
(23 items)
Self-complete or
interviewer
15–20min
(interviewer
format)
English
Marks Asthma
Quality of Life
Questionnaire
(M-AQLQ)23
Aim: to assess quality of life in
adults with asthma
Intended population: adults
with asthma
9 20 items in 4 domains:
Breathlessness (5 items)
Mood (5 items)
Social (7 items)
Concerns (7 items)
Self-complete (but
also used by phone)
Not reported English
Mini-Asthma
Quality of Life
Questionnaire
(mini-AQLQ)21
Aim: to measure the
functional impairments that
are most troublesome to
adult patients as a result of
their asthma
Intended population: adults
4 15 items in 4 domains:
Symptoms (5 items)
Activity limitations (4 items)
Emotional function (3 items)
Environmental stimuli (3 items)
Self-complete 4–5min English
Rhinasthma20 Aim: to evaluate health-
related quality of life
impairment in patients with
rhinitis and/or asthma
Intended population: adults
with rhinitis and/or asthma
2 30 items in 3 domains:
Upper airways
Lower airways and respiratory
allergy impact
A global summary score
Self-complete 5min Italian
St George’s
Respiratory
Questionnaire
(SGRQ)24
Aim: to assess health in
chronic airflow limitation
Intended population: adults
with chronic airflow
limitation
5 76 in 3 domains:
Symptoms
Activity
Impact on daily life
Self-complete
Telephone and
electronic versions
10min English
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Table 1. (Continued )
Instrument Aim of the instrument and
target population
No. of
validation
papers
assessed
No. of items/domains Mode of administration Time to
complete
Original
language
Asthma PROMS for children
Childhood Asthma
Control Test
(C-ACT)32
Aim: to assess asthma control
in children
Intended population:
children with asthma aged
4–11 years
7 7 items in 2 domains:
Child (4 items)
Caregiver (3 items)
Self-complete (child),
and caregiver
Not reported English
Childhood Asthma
Questionnaire
(CAQ)34
Aim: to assess quality of life in
children with asthma
Intended population: CAQ-A,
children 4–7 years; CAQ-B,
children 8–11 years; CAQ-C,
adolescents aged 12–16 years
5 CAQ-A: 14 items
CAQ-B: 23 items
CAQ-C: 46 items
Self-complete, with
help of parents if
needed
10–20min English
Paediatric Asthma
Quality of Life
Questionnaire
(PAQLQ)35
Aim: to measure the
functional impairments that
are most troublesome to
children (7–17 years) as a
result of their asthma
Intended population:
children with asthma aged
7–17 years
2 23 items in 3 domains:
Symptoms (10 items)
Activity (5 items)
Emotional function (8 items)
Self-complete or
interviewer
10–15min English
PedsQL (Asthma
Module)36
Aim: to assess quality of life in
children with asthma
Intended population:
children and adolescents
aged 2–18 years
4 Generic core: 23 items in 4
domains:
Physical functioning (8 items)
Social functioning (5 items)
Emotional functioning (5
items)
School functioning (5 items)
Short-form:15
Asthma module: 28 in 4
domains (Short-form: 22)
Symptoms (11 items)
Treatment problems (11 items)
Worry (3 items)
Communication (3 items)
Self-complete: parallel
child and parent
forms; parent–proxy
only for 2–4 years
5 min
(generic)
Not reported
for asthma
module
English
Asthma PROMs for child’s caregiver
Paediatric Asthma
Caregiver’s Quality
of Life
Questionnaire
(PACQLQ)37
Aim: to measure the
problems that parents of
children with asthma
experience as a result of their
child’s asthma
Intended population: primary
caregivers of children aged
7–17 years with asthma
3 13 items in 2 domains:
Activity limitation (4 items)
Emotional function (9 items)
Self-complete 3–5min English
Abbreviation: PROM, patient-reported outcome measure.
Table 2. Summary of development properties of included PROMs
PROM Pre-study
hypothesis
Intended
population
Actual
content area
(face validity)
Item
identification
Item selection Uni-
dimensionality
Response
scale
Scoring Instrument translated and
validated in English-
speaking population
ACT ✓✓ ✓✓ ✓✓ ✓✓ ✓ ✓ ✓✓ ✓ ✓✓
ACQ ✓✓ ✓✓ ✓✓ ✓✓ ✓ 0 ✓ ✓ ✓✓
AQLQ ✓✓ ✓✓ ✓✓ ✓✓ ✓ 0 ✓ ✓ ✓✓
LWAQ ✓✓ ✓✓ ✓✓ ✓✓ ✓ 0 ✓ ✓ ✓✓
Marks
AQLQ
✓✓ ✓✓ ✓ ✓ ✓✓ ✓ ✓ ✓✓ ✓✓
Mini AQLQ ✓✓ ✓ ✓✓ ✓✓ ✓✓ 0 0 ✓✓ ✓✓
Rhinasthma ✓✓ ✓✓ ✓✓ ✓✓ ✓✓ ✓ ✓✓ ✓ ✓✓
SGRQ 0 0 0 0 0 0 0 0 0
C-ACT ✓✓ ✓✓ ✓✓ ✓✓ ✓✓ 0 ✓✓ ✓ ✓✓
CAQ-B ✓✓ ✓✓ ✓✓ ✓✓ ✓ ✓ ✓ ✓ ✓✓
PAQLQ 0 0 0 0 0 0 0 0 0
PedsQL ✓✓ ✓ ✓✓ ✓✓ ✓ ✓ ✓ ✓✓ ✓✓
PACQLQ ✓✓ ✓✓ ✓✓ ✓✓ ✓✓ 0 ✓ ✓ ✓✓
If not reported, score as ‘0’; ✓✓, positive rating; ✓, minimal acceptable rating; ⨯, negative rating.
Abbreviations: C-ACT, Childhood Asthma Control Test; CAQ, Childhood Asthma Questionnaire; PACQLQ, Paediatric Asthma Caregiver’s Quality of Life
Questionnaire; PAQLQ, Pediatric Asthma Quality of Life Questionnaire; PROM, patient-reported outcome measure; SGRQ, St George's Respiratory Questionnaire.
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patient’s personal perceptions of the impact of asthma on their
quality of life.
Instruments for use in children with asthma
Fewer PROMs for children than adults were identified, although
the value of finding a suitable PROM for children to self-rate their
asthma-related quality of life (QOL) is clear, particularly as parent
and clinician proxy assessments of a child’s asthma-related QOL
may vary greatly from a child’s self-assessment.30 The Pediatric
Asthma Quality of Life Questionnaire31 for children, a derivative of
the AQLQ, has limited validation work published, but is the only
PROM for children with asthma that addresses asthma-related
QOL comprehensively and its performance appeared adequate.
The Childhood Asthma Control Test also offers promise in
assessing asthma control in children, although it requires further
validation work as there has been some debate regarding whether
it estimates poorly controlled asthma accurately.32,33 The Child-
hood Asthma Questionnaire was poorly validated and cannot be
recommended.34 The PedsQL is a generic tool with disease-
specific modules, including one for asthma, a combination that is
potentially useful. Quality appraisal indicated that the develop-
ment of the Generic Core Scales was adequate, but the
performance was variable and the development and performance
of the asthma module was less well described.35,36
Instruments for use with caregivers of children with asthma
The Paediatric Asthma Caregiver’s Quality of Life Questionnaire,
another associated tool of the AQLQ, measures parental QOL
related to their child’s asthma, which may be used in parallel with
the child’s own rating through the Pediatric Asthma Quality of
Life Questionnaire. Quality appraisal of the Paediatric Asthma
Caregiver’s Quality of Life Questionnaire was broadly positive,
based on a limited amount of validation work.37
Generic tools
We identified 28 generic tools that have been evaluated for use in
people with asthma and that may be used in combination with
asthma-specific tools. The most commonly used appear to be the
Sickness Impact Profile,38 the 36-item Short Form Health Survey39
and SF-12.40 The EQ-5D41 has been adopted as the generic tool of
choice for the evaluation of health status pre- and postoperatively
in the National Health Service and for Department of Health-
funded pilot studies on PROMs for long-term conditions, as it
allows comparisons of performance between different conditions,
across services and between providers, and also facilitates cost-
effectiveness analysis.6 This is despite questions being raised
about its fitness for purpose.42 A previous quality appraisal
identified the 36-item Short Form Health Survey and EQ-5D as the
most suitable generic measures in asthma.43 This, however,
requires further testing.
DISCUSSION
Main findings
Our evaluation of existing PROMs for asthma suggests that they
need further validation even for research purposes, particularly
PROMs for children. The psychometric properties in particular
were found to need more robust validation work. Some PROMS,
such as the AQLQ and its derivatives and Rhinasthma, show
promise as being potentially useful in clinical practice and further
validation work should be conducted on these. The mini-AQLQ, as
a relatively compact PROM (15 items), may have particular utility
in clinical practice. PROMs that focus primarily on asthma control,
Table 3. Summary of psychometric properties of included PROMs
PROM Convergent
validity
Discriminant
validity
Predictive
validity
Other evidence for
construct validity, e.g.
criterion, discriminant
Test–retest
agreement
Interobserver
agreement/
intermode
agreement
Person or item
separation
reliability
Interpretation Responsiveness
ACT ✓✓ ✓✓ ✓✓ ✓✓ ✓✓ ✓✓
(intermode)
0 ✓✓ ✓✓
ACQ ✓✓ ✓✓ ✓ ✓✓ ✓✓ ✓✓ 0 ✓ ✓✓
AQLQ ✓✓ 0 0 ✓✓ for severity scale
✓ for FEV1
✓✓ 0 0 ✓ ✓
(✓✓ in
Japanese
and New
Zealand
sample)
AQLQ 12+ 0 0 0 ✓✓ 0 0 0 ✓✓ 0
AQLQ (S) ✓✓ 0 ✓✓ ✓✓ ✓✓ 0 0 ✓✓ 0
LWAQ ✓ 0 ⨯ ✓ ⨯ 0 0 0 0
Marks-
AQLQ
✓ ✓ 0 ✓ ✓✓ 0 0 ✓ ✓
Mini AQLQ ✓✓ 0 ✓✓ ✓✓ ✓ ✓✓
(intermode)
0 0 ✓✓
Rhinasthma ✓✓ 0 0 0 0 0 0 0 0
SGRQ ✓ 0 0 ✓ ✓✓ 0 0 ✓✓ ✓✓
C-ACT ✓✓ ✓ 0 ✓✓ 0 0 0 ✓ 0
CAQ-B 0 0 0 ✓✓ 0 0 0 ✓ 0
PAQLQ ✓✓ ✓✓ 0 ✓✓ ✓✓ 0 0 0 ✓✓
PedsQL ✓✓ 0 0 ✓ 0 0 0 ✓ ✓
PACQLQ ✓✓ ✓✓ 0 ✓✓ ✓✓ 0 0 ✓ ✓
If not reported, score as ‘0’; ✓✓, positive rating; ✓, minimal acceptable rating; ⨯, negative rating.
Abbreviations: ACT, Asthma Control Test; ACQ, Asthma Control Questionnaire; AQLQ, Asthma Quality of Life Questionnaire; C-ACT, Childhood Asthma Control
Test; CAQ, Childhood Asthma Questionnaire; LWAQ, Living With Asthma Questionnaire; PACQLQ, Paediatric Asthma Caregiver’s Quality of Life Questionnaire;
PAQLQ, Pediatric Asthma Quality of Life Questionnaire; SGRQ, St George's Respiratory Questionnaire.
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such as the Asthma Control Test, Asthma Control Questionnaire
and Childhood Asthma Control Test, are inadequate as measures
of HRQL.
The majority of PROMs we appraised were developed for use in
research contexts, such as determining changes in HRQL as part of
a randomised controlled trial of an asthma treatment, rather than
in clinical settings. They may, therefore, be more suitable for group
comparisons, rather than for determining change in an individual’s
QOL over time. PROMs are generally validated at group level and,
although there have been attempts to validate outcome measures
at individual level using qualitative methods,44 this methodology
is poorly developed as yet. This results in a gap in our knowledge
of how to use PROMs with individual patients in clinical practice
and whether they improve asthma management. Importantly,
there has been very little attention paid to the net benefit of
interventions from the patient’s point of view using the burden of
treatment measurements, where patients are asked to weigh the
advantages and drawbacks of an intervention.
Authors of the papers reviewed frequently expressed more
confidence in the reliability and validity of their instruments than
our quality appraisal supported. Many studies provided inade-
quate information on the development or validation of the PROM
and almost none provided information on the minimal clinically
important difference, crucial to determining the clinical signifi-
cance of a change in an individual’s QOL over time, which is a
factor highly relevant to PROMs’ use in clinical settings. Also,
where PROMs were developed in one format but might be used in
different ways, such as face-to-face, online, phone or post,
validation was often arbitrary. Variables such as age, culture and
socioeconomic status were often poorly addressed. Small sample
sizes were common in reported studies.
From the literature and responses from experts we consulted,
some additional PROMs appear to be commonly used in patients
with asthma, notably the Asthma Bother Profile45 and the Royal
College of Physicians Three Questions,46 the latter used particu-
larly in UK primary care. These were too poorly validated to meet
our inclusion criteria. The Asthma Bother Profile, however, appears
potentially useful in clinical settings; it was designed for clinical
contexts and the management questions are potentially useful in
exploring factors that influence self-management skills and
patient perspectives of care; therefore further testing is recom-
mended. The Royal College of Physicians Three Questions,
although recommended for assessment of asthma control in
adults in the UK Asthma Guideline,47 and included as an essential
component of annual asthma review within the Quality and
Outcome Framework,48 has not been developed in the same
rigorous manner or subjected to the same standard of evaluation
as other measures. It provides a quick method of assessing asthma
control and is an indicator of areas for further clinical assessment,
but not a comprehensive estimation of the patient’s asthma-
related QOL.
Strengths and limitations of this study
Few previous studies have looked specifically at PROMs for
asthma, appraised their use in detail using robust criteria or
considered their use in clinical contexts. Asthma provides a good
model for considering PROMs’ use in patients with long-term
conditions and comorbidities.
We may not have identified all available PROMs for asthma, but
our search strategy attempted to address this by using a range of
methods. Poor reporting and inadequate abstracts in some of the
papers we identified may have led to some PROMs being
excluded from full-quality appraisal. The PROMs field is rapidly
expanding, and current validation work on some tools we
excluded in this review, such as the Control of Allergic Rhinitis
and Asthma Test49 and RhinAsthma Patient Perspective,50 which
specifically address comorbid asthma and allergic rhinitis, may yet
prove to be useful additions to the canon.
Interpretation of findings in relation to previously published work
Other studies have focused mainly on evaluating PROMs for
research use and have used a variety of different methods of
appraising PROMs. Apfelbacher et al.51 reviewed asthma PROMs
using their own criteria and concluded that the purpose of
instruments differs widely, tools may be chosen for pragmatic
reasons, such as cultural/linguistic availability and tools should
focus on HRQL, excluding symptom evaluation. Another review of
asthma-related quality of life tools for clinical research was unable
to recommend any existing tools, due to lack of adequate
psychometric data, problems with scoring and a focus on asthma
control rather than quality of life.52 The recently published report
on the Department of Health pilot of PROMs for long-term
conditions in primary care, including asthma, concluded that
existing generic and disease-specific PROMs are less successful for
people with multiple conditions, therefore new types of PROM
which address this growing need will be required.5
Other studies have also reported on the lack of patient
perspectives on PROMs. Active collaboration between clinicians
and patients in PROM development was generally apparent in the
PROMs we appraised. Patient perspectives of completing PROMs
are also important, but under-evaluated,51 and the proposed value
of completing PROMs should be transparent. Response rates from
patients in the recent DH pilot on PROMs use were worryingly low,
38% overall.5 Research by members of our team, however,
administering HRQL questionnaires in an outpatient allergy clinic
setting, identified very high response rates in children (73–94%)
and adults (80–86%) and little questionnaire fatigue.53–55 The
intended use of PROMs by patients to inform effective choices in
health care services requires further examination,8,13 particularly in
relation to informed decision-making and health literacy.56
Implications for future research, policy and practice
It is a matter of concern that so many PROMs for asthma have
been developed but are so poorly validated and barely used. This
adds to the difficulty for clinicians in identifying an appropriate
PROM for practice. It is not always clear why authors decided to
develop new tools, but a common reason appeared to be that
they decided a particular group or specific area of interest was not
covered by existing tools. Given the lack of well-validated PROMs
we identified, we can understand the temptation to start again by
developing new tools which might perform more effectively. It
may be preferable and more pragmatic for research to focus on
developing the methodology for further validation of the most
promising existing tools, including ways of determining their
validity with individual patients. Whether conducting retro-
spective validation of existing PROMs or developing new ones,
the most rigorous statistical methods should be used, such as
Rasch analysis, which enables the examination of the hierarchical
structure, unidimensionality and additivity of PROMs.
Advocating routine PROMs use in clinical practice is challenging
when existing PROMs have been found to be inadequate. Their use
in long-term conditions, where outcomes cannot necessarily be
linked directly to healthcare interventions, requires further
consideration and clarification of purpose. There is no distinct
‘before and after’ in asthma management as there is in a surgical
procedure and clinicians need guidance about what an appro-
priate outcome might be in asthma care, for example reduced
symptom impact, maintenance of function, or lack of deterioration,
and when to measure it. With such a range of PROMs available,
clinicians may have difficulty choosing a tool that is sufficiently well
validated and fit-for-purpose. The unresolved question of how to
use PROMs in patients with comorbidities may be a dilemma for
clinicians in everyday practice.
Patient-reported outcome measures for asthma
A Worth et al
6
npj Primary Care Respiratory Medicine (2014) 14020 © 2014 Primary Care Respiratory Society UK/Macmillan Publishers Limited
CONCLUSIONS
We identified many PROMs for asthma, but only a small number
were of adequate quality for use in research contexts, and even
fewer of these were of potential value in clinical settings. Without
further validation work to assess their appropriateness in clinical
practice with individual patients, it is difficult to recommend these
for routine use. That said, using an imperfectly validated PROM
may still be of clinical benefit if it genuinely addresses patient-
perceived quality of life and its limitations are understood.
Identifying and further developing the best available PROMs
and testing them in clinical practice will support the development
of resources for clinicians to help them use PROMs meaningfully,
such as an online toolkit. Looking ahead, there is a pressing need
to develop PROMs to give a nuanced picture of HRQL in patients
with related multiple clinical conditions.
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